Victor L. Schuster, MD
As a respected leader, clinical physician and professor, Dr. Schuster
serves as University Chair of the Department of Medicine at Einstein
and at Montefiore Medical Center
is active in clinical medicine and teaching, serving as both the Renal Consult Service and the Inpatient Medicine Service attending physician.
received awards from the American Society for Clinical Investigation
(1992) and the Association of American Physicians
(1998) for his
studies of prostanoid signaling.
Dr. Schuster's research has been funded by National Institute of Health for 17 years.
Dr. Schuster earned his medical degree at Washington University, St. Louis in 1977.
He was an intern, resident and chief resident in internal medicine at the University of Washington, Seattle, and was a renal fellow at Southwestern Medical School, Dallas.
first faculty position was at the University of Iowa, Iowa City
In 1988, he moved to Albert Einstein College of Medicine in the Bronx where he became Chief of the Einstein Renal Division in 1992 and Chief of the Unified Renal Division (Einstein and Montefiore) in 1998.
From 1993 to 1998, Dr. Schuster was also Director, Division of Nephrology, and he served as Vice-Chairman for Research from 2000 to 2002.
has studied vasoactive hormones and epithelial transport for 25 years and his
laboratory was the first to show that angiotensin II directly modulates fluid reabsorption by the proximal tubule.
spent a decade working in acid-base physiology, characterizing the respective transporters of renal collecting duct α and β intercalated cells.
In 1995, his
laboratory discovered the prostaglandin (PG) transporter "PGT", a finding he
has extended to human and mouse genetics, carcinogenesis, zebrafish development, vascular disease and biotechnology.
laboratory has advanced the hypothesis that PG signaling is akin to neuronal signaling, i.e. the signaling molecule is released and then taken up again by the same cell.
Because PGT regulates the expression of, and signaling via, PG receptors, it comprises a new therapeutic target for modulating prostanoid signaling.
Dr. Schuster lectures on clinical cases of renal physiology, renal pathophysiology, renal disease, prostaglandin signaling, and non-steroidal drug design to house staff and Einstein students.
He is also the Treasurer of the International Society of Nephrology and serves on the Board of Directors of the Association of Professors of Medicine (Department of Medicine chairs organization).